Clinical trial / 2014
Nigella sativa seed powder improved lipid profiles in hyperlipidemic menopausal women.
In a randomized trial, 37 hyperlipidemic menopausal women received Nigella sativa seed powder (n=19) or placebo (n=18) for two months. Nigella sativa intake significantly reduced total cholesterol, LDL cholesterol, and triglycerides while increasing HDL cholesterol compared with placebo. One month following treatment cessation, lipid values in the intervention group tended to shift back toward baseline concentrations.
- Study type
- Randomized controlled trial
- Who was studied
- 37 hyperlipidemic menopausal women
- What was measured
- Blood lipid profile (total cholesterol, LDL, HDL, triglycerides)
THE PAPER
A randomised controlled trial on hypolipidemic effects of Nigella Sativa seeds powder in menopausal women.
Ibrahim RM, Hamdan NS, Mahmud R, Imam MU, Saini SM, Rashid SN, Abd Ghafar SA, Latiff LA, Ismail M. J Transl Med, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.